- Home
- BDSX vs ARL Comparison
BDSX vs ARL Comparison
Compare BDSX & ARL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDSX
- ARL
- Stock Information
- Founded
- BDSX 2005
- ARL 1999
- Country
- BDSX United States
- ARL United States
- Employees
- BDSX N/A
- ARL N/A
- Industry
- BDSX Precision Instruments
- ARL Building operators
- Sector
- BDSX Health Care
- ARL Real Estate
- Exchange
- BDSX Nasdaq
- ARL Nasdaq
- Market Cap
- BDSX 200.0M
- ARL 231.0M
- IPO Year
- BDSX 2020
- ARL N/A
- Fundamental
- Price
- BDSX $1.20
- ARL $15.27
- Analyst Decision
- BDSX Strong Buy
- ARL
- Analyst Count
- BDSX 4
- ARL 0
- Target Price
- BDSX $3.08
- ARL N/A
- AVG Volume (30 Days)
- BDSX 732.5K
- ARL 20.4K
- Earning Date
- BDSX 11-01-2024
- ARL 11-07-2024
- Dividend Yield
- BDSX N/A
- ARL N/A
- EPS Growth
- BDSX N/A
- ARL N/A
- EPS
- BDSX N/A
- ARL N/A
- Revenue
- BDSX $65,562,000.00
- ARL $51,029,000.00
- Revenue This Year
- BDSX $46.97
- ARL N/A
- Revenue Next Year
- BDSX $30.43
- ARL N/A
- P/E Ratio
- BDSX N/A
- ARL N/A
- Revenue Growth
- BDSX 48.92
- ARL 0.87
- 52 Week Low
- BDSX $1.11
- ARL $12.51
- 52 Week High
- BDSX $2.21
- ARL $25.96
- Technical
- Relative Strength Index (RSI)
- BDSX 28.77
- ARL 55.87
- Support Level
- BDSX $1.11
- ARL $13.11
- Resistance Level
- BDSX $1.45
- ARL $14.35
- Average True Range (ATR)
- BDSX 0.09
- ARL 0.78
- MACD
- BDSX -0.02
- ARL 0.13
- Stochastic Oscillator
- BDSX 24.32
- ARL 78.65
About BDSX Biodesix Inc.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
About ARL American Realty Investors Inc.
American Realty Investors Inc is a real estate company. The company acquires, develops, and owns income-producing residential and commercial real estate properties. Its segment involves the Residential segment and the Commercial segment. The residential segment is engaged in the acquisition, development, ownership, and management of multifamily properties and the Commercial segment is engaged in the acquisition, ownership, and management of commercial real estate properties. Its holdings include apartments, office buildings, retail centers, and parcels of land.